Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Luca A. Vricella is active.

Publication


Featured researches published by Luca A. Vricella.


Pediatric Anesthesia | 2002

Single lung ventilation in children using a new paediatric bronchial blocker

Gregory B. Hammer; T. Kyle Harrison; Luca A. Vricella; Michael D. Black; Elliot J. Krane

As video‐assisted thoracoscopic surgery has become more common in paediatric patients, the use of single lung ventilation in children has also increased. Single lung ventilation in young children is performed by either advancing a tracheal tube into the mainstem bronchus opposite the side of surgery or by positioning a bronchial blocker into the mainstem bronchus on the operative side. Techniques for placing a variety of bronchial blockers outside the tracheal tube have been described. We describe a technique for placement of a new bronchial blocker through an indwelling tracheal tube using a multiport adaptor and a fibreoptic bronchoscope.


The Annals of Thoracic Surgery | 2002

Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the Stanford experience.

Luca A. Vricella; John M. Karamichalis; Shahzad Ahmad; Robert C. Robbins; Richard I. Whyte; Bruce A. Reitz

BACKGROUND Bilateral lung (BLTx) and heart-lung transplantation have gained wide acceptance as treatment of end-stage lung disease from cystic fibrosis. We reviewed our 13-year experience with thoracic transplantation for cystic fibrosis with an operative approach that favors use of cardiopulmonary bypass for BLTx. METHODS Sixty-four patients with cystic fibrosis underwent heart-lung transplantation (n = 22, 34.4%) or BLTx (n = 42, 65.6%) between 1988 and 2000. Mean age and weight at transplantation were 29 +/- 8 years and 51 +/- 11 kg, respectively. Mean follow-up for survivors was 4.4 +/- 3.6 years. Immunosuppression regimen included cyclosporine, tapered corticosteroids, azathioprine, and induction therapy with OKT3 (murine monoclonal antibodies) or rabbit antithymocyte globulin. Cardiopulmonary bypass was used in all but 5 patients (7.8%). However, in 8 (19%) of the 42 patients having BLTx, only the grafting of the second lung was performed with cardiopulmonary bypass. RESULTS The operative mortality rate was 1.6%. The actuarial survival rates at 1 year, 3 years, 5 years and 10 years were 93.2%, 77.7%, 61.8%, and 48.1%, respectively, with no significant difference between BLTx and heart-lung transplantation. The major hospital complications were pneumonia (n = 11, 17.2%) and bleeding (n = 8, 12.5%). Clinically significant reperfusion injury was observed in 6 patients, 3 of whom required reintubation. Freedom from acute lung rejection beyond 1 year was 47.7%. One patient underwent late retransplantation, and 4 required bronchial stenting. Obliterative bronchiolitis accounted for eight (50.0%) of 16 late deaths. CONCLUSIONS Though postoperative bleeding and pneumonia are still of concern, satisfactory early and intermediate-term results can be expected in patients undergoing BLTx or heart-lung transplantation for cystic fibrosis. Cardiopulmonary bypass can be used for BLTx with no adverse impact on intermediate and long-term outcomes.


The Annals of Thoracic Surgery | 2003

Simplified technique for correction of anomalous origin of left coronary artery from the anterior aortic sinus

John M. Karamichalis; Luca A. Vricella; Daniel J. Murphy; Bruce A. Reitz

Anomalous origin of the left main coronary artery from the right anterior coronary sinus has been associated with high incidence of sudden death in young adults. We describe a simplified approach to this rare congenital anomaly, which avoids the need for commissural post resuspension or relocation of the coronary button.


Urology | 2003

Cavoatrial tumor thrombus excision without circulatory arrest.

Rajesh Shinghal; Luca A. Vricella; R. Scott Mitchell; Joseph C. Presti

INTRODUCTION Traditional methods of cavoatrial thrombus excision use deep hypothermic circulatory arrest with significant associated morbidity and mortality. We describe a novel technique that avoids circulatory arrest, yet provides a bloodless field for tumor excision. TECHNICAL CONSIDERATIONS A 59-year-old woman presented with a left renal mass and tumor thrombus with extension into the right atrium. After left radical nephrectomy, an aortic occlusion balloon was placed in the abdominal aorta at the level of the diaphragm, limiting flow in the inferior vena cava for tumor excision and maintaining both cerebral and spinal cord perfusion during cardiopulmonary bypass. Tumor excision was successfully performed using this technique with minimal postoperative morbidity in the patient described. She remained free of recurrence at 9 months of follow-up. CONCLUSIONS Cavoatrial tumor thrombus excision can be successfully performed without deep hypothermic circulatory arrest.


Asian Cardiovascular and Thoracic Annals | 2004

Simplified antegrade cerebral perfusion and myocardial protection during stage I Norwood procedure.

Luca A. Vricella; Piya Samankatiwat; Marc R. de Leval; Victor Tsang; Pascal Vouhé

Several important modifications have been introduced in the intraoperative management of neonates with hypoplastic left heart syndrome during first-stage palliation. Among these, utilization of selective antegrade cerebral perfusion and interposition of a conduit between the right ventricle and pulmonary artery are currently favored by many centers. We briefly describe our current approach to the modified stage I Norwood procedure.


Perfusion | 2007

Modification of an extracorporeal life support circuit for intraoperative correction of complex congenital heart disease

Toomasian Jm; Luca A. Vricella; Michael D. Black

Extracorporeal life support (ECLS) was established in a newborn infant diagnosed with severe respiratory failure secondary to complex congenital heart disease. After 4 days of ECLS support in the intensive care unit, the infant was brought to the operating room for repair of the primary lesion. Due to concerns related to recurrent respiratory failure associated with blood contact to a new extracorporeal circuit, the existing ECLS circuit was modified for use in the operating room. This report describes the circuit modification steps and challenges related to running a modified ECLS circuit for cardiopulmonary support during cardiac surgery. Perfusion (2007) 22, 35—40.


Asian Cardiovascular and Thoracic Annals | 2002

Adult Presentation of Complete Atrioventricular Septal Defect

Murray H. Kown; Luca A. Vricella; Christopher T Salerno; David N. Rosenthal; Michael D. Black

Complete atrioventricular septal defect generally presents early in life with symptoms of congestive heart failure. Untreated, patients almost universally develop irreversible pulmonary hypertension. We present an unusual case of a Downs syndrome patient whose septal defect first presented at 20 years of age.


The Annals of Thoracic Surgery | 2004

Regression of severe pulmonary arteriovenous malformations after Fontan revision and "hepatic factor" rerouting

Nancy A. Pike; Luca A. Vricella; Jeffrey A. Feinstein; Michael D. Black; Bruce A. Reitz


The Journal of Thoracic and Cardiovascular Surgery | 2003

Initial experience with a stentless porcine bioprosthesis for right ventricular outflow tract reconstruction in children.

Luca A. Vricella; Michael A. Coady; Michael D. Black


The Journal of Thoracic and Cardiovascular Surgery | 2002

Aortic arch reconstruction in neonates without hypothermic circulatory arrest.

Luca A. Vricella; Michael D. Black; Yutaka Imoto; Hideaki Kado

Collaboration


Dive into the Luca A. Vricella's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge